VRS
ALNY icon

Virginia Retirement Systems’s Alnylam Pharmaceuticals ALNY Stock Holding History

Virginia Retirement Systems’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
3,980
+2,620
+193% +$790K 0.01% 696
2026
Q1 		$450K Buy
+1,360
New +$463K ﹤0.01% 782
2020
Q2 		– Sell
-4,800
Closed -$522K – 1091
2020
Q1 		$522K Buy
+4,800
New +$554K 0.01% 780

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virginia Retirement Systems's ALNY Position: Q2 2026 in Review

Virginia Retirement Systems increased its Alnylam Pharmaceuticals (ALNY) stake by 193% in Q2 2026, buying an estimated $790K and bringing the position to 3,980 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #696.

Virginia Retirement Systems first reported a position in ALNY in Q1 2020 and has held it in 3 quarters since. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Virginia Retirement Systems held 3,980 shares of Alnylam Pharmaceuticals worth $1.2M as of Q2 2026.
  • Virginia Retirement Systems bought 2,620 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $790K.
  • Alnylam Pharmaceuticals made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #696 holding.
  • Virginia Retirement Systems first reported a position in Alnylam Pharmaceuticals in Q1 2020 and has held it in 3 quarters since.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.